From 2012.igem.org
(Difference between revisions)
|
|
| (One intermediate revision not shown) |
| Line 1: |
Line 1: |
| - | {{Template:WUR}}
| |
| | | | |
| - | =General Overview=
| |
| - |
| |
| - |
| |
| - | The use of Virus-Like-Particles as medicine carrier is new for iGEM. This means the whole production, purification and detection of Virus-Like-Particles is also new in iGEM. In this section we will explain how the different methods work and how it all fits together.
| |
| - |
| |
| - |
| |
| - | The production of our VLPs monomers is done in E.coli, while the formation of our VLPs is done in vitro. We used multiple techniques to make this happen. [[Team:Wageningen_UR/MethodsProduction|Click here to read more]]
| |
| - |
| |
| - |
| |
| - | After the production of our VLPs we have our formed VLPs, but this product is not pure enough. So we developed a two step method to purify the product. [[Team:Wageningen_UR/MethodsPurification|Click here to read more]]
| |
| - |
| |
| - |
| |
| - | The most difficult and possible the most expensive thing is the detection of our VLPs. We found multiple methods that can help us. [[Team:Wageningen_UR/MethodsDetection|Click here to read more]]
| |
Latest revision as of 11:52, 13 September 2012
"
